BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 2163761)

  • 1. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.
    Haber DA; Buckler AJ; Glaser T; Call KM; Pelletier J; Sohn RL; Douglass EC; Housman DE
    Cell; 1990 Jun; 61(7):1257-69. PubMed ID: 2163761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
    Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
    Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.
    Call KM; Glaser T; Ito CY; Buckler AJ; Pelletier J; Haber DA; Rose EA; Kral A; Yeger H; Lewis WH
    Cell; 1990 Feb; 60(3):509-20. PubMed ID: 2154335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
    Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
    Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.
    Tadokoro K; Fujii H; Ohshima A; Kakizawa Y; Shimizu K; Sakai A; Sumiyoshi K; Inoue T; Hayashi Y; Yamada M
    Oncogene; 1992 Jun; 7(6):1215-21. PubMed ID: 1350671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping.
    Gessler M; Poustka A; Cavenee W; Neve RL; Orkin SH; Bruns GA
    Nature; 1990 Feb; 343(6260):774-8. PubMed ID: 2154702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of kidney complementary DNAs down-expressed in Wilms' tumor by a subtractive hybridization approach.
    Austruy E; Cohen-Salmon M; Antignac C; Béroud C; Henry I; Nguyen VC; Brugières L; Junien C; Jeanpierre C
    Cancer Res; 1993 Jun; 53(12):2888-94. PubMed ID: 7916648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
    Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
    Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.
    Algar EM; Kenney MT; Simms LA; Smith SI; Kida Y; Smith PJ
    Hum Mutat; 1995; 5(3):221-7. PubMed ID: 7599632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A third Wilms' tumor locus on chromosome 16q.
    Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
    Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor.
    Coppes MJ; Liefers GJ; Paul P; Yeger H; Williams BR
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1416-9. PubMed ID: 8381965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
    Cowell JK; Groves N; Baird P
    Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene.
    Telerman A; Dodemont H; Degraef C; Galand P; Bauwens S; Van Oostveldt P; Amson RB
    Oncogene; 1992 Dec; 7(12):2545-8. PubMed ID: 1334252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome.
    Gessler M; König A; Moore J; Qualman S; Arden K; Cavenee W; Bruns G
    Genes Chromosomes Cancer; 1993 Jul; 7(3):131-6. PubMed ID: 7687865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S; Tomlinson G; Nisen P; Haber DA
    Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations.
    Schneider S; Wildhardt G; Ludwig R; Royer-Pokora B
    Hum Genet; 1993 Jul; 91(6):599-604. PubMed ID: 8393425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity.
    Wang WH; Duan JX; Vu TH; Hoffman AR
    J Biol Chem; 1996 Nov; 271(44):27863-70. PubMed ID: 8910385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK; Brown KW; Berry PJ
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing of exon 5 in the WT1 gene is disrupted in Wilms' tumour.
    Simms LA; Algar EM; Smith PJ
    Eur J Cancer; 1995 Dec; 31A(13-14):2270-6. PubMed ID: 8652255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.
    Haber DA; Buckler AJ
    New Biol; 1992 Feb; 4(2):97-106. PubMed ID: 1313285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.